(Q38097525)

28 August 2017

title

Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies (English)

1 reference

28 August 2017

José Antonio Lorente

2

0 references

Rafael Rosell

series ordinal

3

object named as

Rafael Rosell

1 reference

28 August 2017

Rosa Nadal

1

1 reference

28 August 2017

María Jose Serrano

series ordinal

4

1 reference

28 August 2017

publication date

1 April 2013

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

28 August 2017

published in

1 reference

28 August 2017

volume

13

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

295-307

1 reference

28 August 2017

cites work

Cancer statistics, 2012

1 reference

Dissecting the metastatic cascade

21 January 2018

1 reference

Systemic spread is an early step in breast cancer

21 January 2018

1 reference

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

21 January 2018

1 reference

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.

21 January 2018

1 reference

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

21 January 2018

1 reference

Circulating tumour cells in non-metastatic breast cancer: a prospective study

21 January 2018

1 reference

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer

21 January 2018

1 reference

Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance

21 January 2018

1 reference

Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection

21 January 2018

1 reference

Tumor cell detection in peripheral blood and bone marrow

21 January 2018

1 reference

Circulating tumor cells (CTC) detection: clinical impact and future directions.

21 January 2018

1 reference

Principles of cancer therapy: oncogene and non-oncogene addiction

21 January 2018

1 reference

HER-2 gene amplification can be acquired as breast cancer progresses

21 January 2018

1 reference

Biomarkers characterization of circulating tumour cells in breast cancer patients

21 January 2018

1 reference

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

21 January 2018

1 reference

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

21 January 2018

1 reference

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

EGFR antagonists in cancer treatment

21 January 2018

1 reference

Targeted therapy of cancer: new roles for pathologists in identifying GISTs and other sarcomas

21 January 2018

1 reference

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study.

21 January 2018

1 reference

Parallel progression of primary tumours and metastases

21 January 2018

1 reference

Molecular requirements for epithelial-mesenchymal transition during tumor progression

21 January 2018

1 reference

A perspective on cancer cell metastasis

21 January 2018

1 reference

Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer

21 January 2018

1 reference

Epithelial-to-mesenchymal transitions and circulating tumor cells

21 January 2018

1 reference

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer

21 January 2018

1 reference

Circulating cancer cells in division in an early breast cancer patient.

21 January 2018

1 reference

Tumor self-seeding by circulating cancer cells

21 January 2018

1 reference

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study

21 January 2018

1 reference

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.

21 January 2018

1 reference

Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.

21 January 2018

1 reference

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

21 January 2018

1 reference

Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy.

21 January 2018

1 reference

21 January 2018

Cancer micrometastases

1 reference

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.

21 January 2018

1 reference

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

21 January 2018

1 reference

Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.

21 January 2018

1 reference

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

21 January 2018

1 reference

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes

21 January 2018

1 reference

Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells

21 January 2018

1 reference

Epithelial-mesenchymal transition and cell cooperativity in metastasis

21 January 2018

1 reference

Cadherins and catenins: role in signal transduction and tumor progression

21 January 2018

1 reference

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

21 January 2018

1 reference

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

21 January 2018

1 reference

Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

21 January 2018

1 reference

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

21 January 2018

1 reference

Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal.

21 January 2018

1 reference

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

21 January 2018

1 reference

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

21 January 2018

1 reference

Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.

21 January 2018

1 reference

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

21 January 2018

1 reference

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

21 January 2018

1 reference

Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling

21 January 2018

1 reference

Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization.

21 January 2018

1 reference

Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.

21 January 2018

1 reference

Breast cancer assessment tools and optimizing adjuvant therapy.

21 January 2018

1 reference

Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact

21 January 2018

1 reference

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.

21 January 2018

1 reference

Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.

21 January 2018

1 reference

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients

21 January 2018

1 reference

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

21 January 2018

1 reference

Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.

21 January 2018

1 reference

Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.

21 January 2018

1 reference

Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.

21 January 2018

1 reference

Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors

21 January 2018

1 reference

HER2-positive circulating tumor cells in breast cancer

21 January 2018

1 reference

Molecular biomarker analyses using circulating tumor cells

21 January 2018

1 reference

Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.

21 January 2018

1 reference

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

21 January 2018

1 reference

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

21 January 2018

1 reference

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group

21 January 2018

1 reference

Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop

21 January 2018

1 reference

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

21 January 2018

1 reference

Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine

21 January 2018

1 reference

Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

21 January 2018

1 reference

Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.13.7

1 reference

release_l72w4rdy5nbzpjlseejbl6b32e

28 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l72w4rdy5nbzpjlseejbl6b32e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference